Reape Kathleen 4
4 · Taysha Gene Therapies, Inc. · Filed Jun 26, 2023
Insider Transaction Report
Form 4
Reape Kathleen
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-22+36,200→ 36,200 totalExercise: $0.72Exp: 2033-06-22→ Common Stock (36,200 underlying)
Footnotes (1)
- [F1]The shares vest on the earlier of June 22, 2024 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.